DIWALI SPECIAL

25% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim Offer →
logo

SURAKSHA vs THYROCARE: Stock Comparison

SURAKSHA DIAGNOSTIC vs THYROCARE TECHUpdated 13 Nov 26, 4:08 PM ISTNSE & company filings

THYROCARE TECH is the larger company by market capitalisation. SURAKSHA DIAGNOSTIC shows a lower P/E and faster revenue growth, while THYROCARE TECH shows a higher ROE, a higher dividend yield and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

SURAKSHA leads 5; THYROCARE leads 8 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

SURAKSHATHYROCARE

Valuation lens

What price are you paying?

Market CapContext only
₹1,801 Cr
₹7,926 Cr
P/E RatioSURAKSHA has the lower reading
43.06x ✓
54.97x
P/B RatioSURAKSHA has the lower reading
6.52x ✓
14.32x
EPSSURAKSHA has the higher reading
₹2.5 ✓
₹1
Book ValueContext only
₹46.75
₹36.82
Dividend YieldTHYROCARE has the higher reading
0.29%
1.41% ✓

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
THYROCARE is the larger company
₹7,926 Cr vs ₹1,801 Cr
P/E Ratio
SURAKSHA has a lower P/E
43.06x vs 54.97x
P/B Ratio
SURAKSHA has a lower P/B
6.52x vs 14.32x
EPS
SURAKSHA has higher earnings per share
₹2.5 vs ₹1
Dividend Yield
THYROCARE has a higher dividend yield
1.41% vs 0.29%
Revenue Growth (TTM YoY)
SURAKSHA has faster revenue growth
31.2% vs 19.7%
EPS Growth (TTM YoY)
THYROCARE has faster EPS growth
116.3% vs -5.4%
Qtr Sales Growth
THYROCARE has stronger quarterly sales growth
12.83% vs 0%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricSURAKSHATHYROCARE
SectorHealthcareHealthcare
IndustryHealthcare Service ProviderHealthcare Service Provider

Price

MetricSURAKSHATHYROCARE
Live Price₹341.7₹498.25
Day Change0.21%2.1%
Volume1.26 L2.22 L
52-Week High₹384₹1,610
52-Week Low₹224.1₹342.55
Distance from 52W High-11.02%-69.05%

Valuation

MetricSURAKSHATHYROCARE
Market Cap₹1,801 Cr₹7,926 Cr
P/E Ratio43.06x54.97x
P/B Ratio6.52x14.32x
EPS₹2.5₹1
Book Value₹46.75₹36.82
Dividend Yield0.29%1.41%

Growth

MetricSURAKSHATHYROCARE
Revenue Growth (TTM YoY)31.2%19.7%
EPS Growth (TTM YoY)-5.4%116.3%
Qtr Sales Growth0%12.83%
Qtr Profit Growth0%-70.35%

Profitability & Leverage

MetricSURAKSHATHYROCARE
ROE13.64%26.54%
ROCE15.19%28.32%
Net Margin10.37%19.67%
Operating Margin19.81%27.46%
Debt to Equity0.01x0x

Shareholding

As of Sep 2026 • change vs previous quarter
MetricSURAKSHATHYROCARE
Promoter Holding49.1%51.02%▼ 9.9 pp
FII Holding13.97%▲ 0.5 pp9.37%▲ 3.93 pp
DII Holding21.56%▼ 1.67 pp25.92%▲ 5 pp
Public Holding15.37%▲ 1.16 pp13.7%▲ 0.98 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: SURAKSHA DIAGNOSTIC and THYROCARE TECH.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.